[ad_1]
This requires increased vaccine production and distribution capacity, adequate preparation for mass vaccination and effective communication, wrote G. Nausėda, who is attending a remote meeting of the European Council (ECC), on Twitter Thursday night.
Before the meeting, he said the EU should aim to vaccinate a critical mass of society by the summer, thus forming a herd immunity. The president also said that with current vaccine delivery volumes, it would be possible to vaccinate less than a third of the public, but it is encouraging that vaccines from other manufacturers are being approved.
So far, the EU has approved two coronavirus vaccines. Last month, the community began vaccinating BionTech and Pfizer, and Moderna approved the vaccine in early January. Following the announcement of a temporary reduction in the supply of the first vaccine, it is currently only used for the booster vaccination.
Lithuania buys vaccines against the coronavirus together with other European Union countries from six companies: Moderna, AstraZeneca, Janssen Pharmaceutica NV, Sanofi and GSK, BioNTech and Pfizer and CureVac.
[ad_2]
